Financial insights of BIOF

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenues	-	-	-	0
General and administrative	274,585	289,984	350,577	431,134
Research and development	384,913	997,486	485,677	471,470
Total operating expenses	659,498	1,287,470	836,254	902,604
Loss from operations	-659,498	-1,287,470	-836,254	-902,604
Interest expense - other	-	-	5	1
Grants income	-	0	420,030	0
Interest expense - related party	-	1.25*	6,328	18,149
Interest expensed or (earned) - other	-	2.25*	-	-
Interest expense - related party	4,303	-	-	-
Total other (income) expense	-4,303	1	413,707	-18,148
Income (loss) before provisions for income taxes	-663,801	-1,287,469	-422,547	-920,752
Provisions for income taxes	-	-	-	0
Net income (loss)	-663,801	-1,287,469	-422,547	-920,752

Basic EPS	-0.002	-0.004	-0.001	-0.003
Diluted EPS	-0.002	-0.004	-0.001	-0.003
Basic Average Shares	319,225,834	318,082,618	312,167,546	310,047,521
Diluted Average Shares	319,225,834	318,082,618	312,167,546	310,047,521

Unit: Dollar. Numbers labeled with * are estimated quarterly values.